Search for: "Boehringer Ingelheim, Inc." Results 1 - 20 of 154
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Apr 2020, 9:57 pm by Patent Docs
Plaintiffs-Appellants Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Corp.; and Boehringer Ingelheim... [read post]
20 Nov 2012, 8:32 am by fraudfighters
  This settlement was with pharmaceutical giant Boehrigner Ingelheim Pharmaceuticals Inc. [read post]
8 Nov 2007, 8:01 pm
By Sherri Oslick -- Ranbaxy Laboratories, Astellas Pharma US, Inc., and Boehringer Ingelheim Corporation have announced their agreement to enter into a joint stipulation of dismissal without prejudice in their lawsuit over FLOMAX ® (tamsulosin hydrochloride, used to treat benign prostatic hyperplasia). [read post]
28 Oct 2012, 6:37 pm
Boehringer Ingelheim Pharmaceuticals Inc., a Germany-based pharmaceutical company that markets and sells drugs in the United States, has recently agreed to settle claims that it illegally promoted four of its best-selling drugs for $95 million. [read post]
8 May 2016, 9:59 pm by Patent Docs
KG; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
13 May 2010, 4:44 pm by mcarzima@imediainc.com
  The companies, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Roxane Inc., Ben Venue Laboratories Inc. and Roxane Laboratories Inc., are all affiliates of German drug giant, Boehringer Ingelheim GmbH. [read post]
9 Aug 2009, 4:54 pm
Boehringer Ingelheim Pharma GmbH & Co. [read post]
26 Oct 2012, 4:31 am by Ben Vernia
According to DOJ’s press release: Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has agreed to pay $95 million to resolve allegations relating to the improper promotion of the stroke-prevention drug Aggrenox, the chronic obstructive pulmonary disease (COPD) drugs Atrovent and Combivent, and the hypertension drug Micardis, the Justice Department announced today. [read post]
27 Jun 2008, 6:35 am
Barr Pharmaceuticals Inc. and Mylan Inc. invalidated a patent (4,886,812) of Boehringer Ingelheim on Mirapex in D. [read post]
2 May 2013, 10:30 am by Amanda Greenburg
On March 26, 2013, Plaintiff Lisa Mulhall filed a claim in the Illinois Southern District Court against the manufacturers of Pradaxa, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH, for causing her mother’s death. [read post]
25 Jul 2012, 4:03 pm by Leon Aussprung
A man from Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
25 Jul 2012, 4:03 pm by Leon Aussprung
A man from Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
25 Jul 2012, 9:03 pm
A man from Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
6 Aug 2012, 2:29 pm
A man has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
25 Jul 2012, 4:03 pm by Leon Aussprung
A man from Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
22 Mar 2012, 1:15 pm by Tom Lamb
New Case Report About Routine Fall Involving An Elderly Patient That Results In Fatal Irreversible Brain Hemorrhage (Posted by Tom Lamb at DrugInjuryWatch.com)  Pradaxa® is the name under which Boehringer Ingelheim Pharmaceuticals, Inc. markets a prescription anticoagulant medication generically called dabigatran. [read post]
8 Jul 2012, 9:13 pm by Patent Docs
• Defendants: Roxane Laboratories, Inc.; Boehringer Ingelheim Roxane, Inc. [read post]
3 Jun 2014, 4:41 pm
That same year, Boehringer Ingelheim Pharmaceuticals, Inc. made $1.5 billion in sales of Pradaxa. [read post]